# Akari Therapeutics Plc: Form DEF 14A, filed Jun 6, 2025

- Company: [Akari Therapeutics Plc](/companies/aktx.md) (CIK 1541157)
- Form: DEF 14A
- Filed: 2025-06-06
- Accepted by EDGAR: Jun 6, 2025, 16:05 ET
- Period: 2025-06-06
- Accession: 0001641172-25-014023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1541157/000164117225014023/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1541157/000164117225014023/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1541157/000164117225014023/formdef14a.htm

Filed Jun 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-014023. Last ingested by Listed: Oct 30, 2026, 17:09 ET. No prices; not investment advice.